文献速递细菌感染、耐药与抗菌药物医院感染防控

随访血培养阳性可识别革兰阴性菌菌血症高死亡风险患者

Positive follow-up blood cultures identify high mortality risk among patients with Gram-negative bacteraemia.
PubMed 文献 · Clin Microbiol Infect · 2020-02-28

该研究在2002至2015年纳入1702例革兰阴性菌菌血症成人住院患者,其中1164例进行了随访血培养。随访血培养阳性率20%,且阳性与全因及归因死亡率升高独立相关,而获取随访血培养与死亡率降低相关。

要点

  • 革兰阴性菌菌血症患者随访血培养阳性率可达20%。
  • 随访血培养阳性与全因死亡风险升高独立相关(HR 2.099)。
  • 获取随访血培养与全因死亡风险降低相关(HR 0.629)。

核心结论

  • 随访血培养阳性率高,且能识别死亡风险升高的革兰阴性菌菌血症患者。
  • 获取随访血培养与全因及归因死亡率降低相关,阳性则与死亡率升高相关。

研究设计与样本

  • 观察性研究,前瞻性纳入2002至2015年Duke University Health System成人住院革兰阴性菌菌血症患者。
  • 共纳入1702例患者,其中1164例(68%)进行了随访血培养。
  • 随访血培养定义为初始血培养阳性后24小时至7天内采集的血培养。

主要发现

  • 随访血培养阳性率为20%(228/1113)。
  • 获取随访血培养者全因住院死亡率15%(176/1164) vs 未获取者20%(108/538),p 0.01。
  • 获取随访血培养者归因住院死亡率8%(98/1164) vs 未获取者15%(78/538),p < 0.0001。
  • 倾向评分加权Cox模型显示获取随访血培养与全因死亡风险降低相关(HR 0.629;95%CI 0.511-0.772;p < 0.0001)。
  • 随访血培养阳性者全因死亡率21%(49/228) vs 阴性者11%(110/885),p 0.0005;阳性与全因死亡风险升高相关(HR 2.099;95%CI 1.567-2.811;p < 0.0001)。

关键数值与推荐

  • 随访血培养阳性者归因死亡率12%(27/228) vs 阴性者7%(61/885),p 0.01。
  • 阳性随访血培养与归因死亡风险升高相关(HR 1.800;95%CI 1.245-2.603;p 0.002)。
  • 获取随访血培养与归因死亡风险降低相关(HR 0.628;95%CI 0.480-0.820;p 0.0007)。
  • 校准分析显示一种评分系统能准确识别随访血培养阳性的高风险患者。

临床怎么用

  • 在革兰阴性菌菌血症管理中应考虑进行随访血培养。
  • 可利用临床变量识别随访血培养阳性的高风险患者。
  • 随访血培养阳性结果提示需关注更高的死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The role of follow-up blood cultures (FUBCs) in the management of Gram-negative bacteraemia (GNB) is poorly understood. We aimed to determine the utility of FUBCs in identifying patients with increased mortality risk. METHODS: An observational study with a prospectively enrolled cohort of adult inpatients with GNB was conducted at Duke University Health System from 2002 to 2015. FUBCs were defined as blood cultures performed from 24 hours to 7 days from initial positive blood culture. RESULTS: Among 1702 patients with GNB, 1164 (68%) had FUBCs performed. When performed, FUBCs were positive in 20% (228/1113) of cases. FUBC acquisition was associated with lower all-cause in-hospital mortality (108/538, 20%, vs. 176/1164, 15%; p 0.01) and attributable in-hospital mortality (78/538, 15%, vs. 98/1164, 8%; p < 0.0001). Propensity score-weighted Cox proportional hazards models revealed that obtaining FUBCs was associated with reductions in all-cause (hazard ratio (HR) 0.629; 95% confidence interval (CI), 0.511-0.772; p < 0.0001) and attributable mortality (HR 0.628; 95% CI, 0.480-0.820; p 0.0007). Positive FUBCs were associated with increased all-cause mortality (49/228, 21%, vs. 110/885, 11%; p 0.0005) and attributable mortality (27/228, 12%, vs. 61/885, 7%; p 0.01) relative to negative FUBCs. Propensity score-weighted Cox proportional hazards models revealed that positive FUBCs were associated with increased all-cause (HR 2.099; 95% CI, 1.567-2.811; p < 0.0001) and attributable mortality (HR 1.800; 95% CI, 1.245-2.603; p 0.002). In a calibration analysis, a scoring system accurately identified patients at high risk of positive FUBCs. CONCLUSIONS: Rates of positive FUBCs were high and identified patients at increased risk for mortality. Clinical variables can identify patients at high risk for positive FUBCs. FUBCs should be considered in the management of GNB.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Maskarinec SA, Park LP, Ruffin F, et al. Positive follow-up blood cultures identify high mortality risk among patients with Gram-negative bacteraemia. Clin Microbiol Infect. 2020. PMID: 32114010. doi:10.1016/j.cmi.2020.01.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。